Liver Health

Nonalcoholic Steatohepatitis (NASH), affecting many with nonalcoholic fatty liver disease, stands as a significant public health concern. Characterized by liver inflammation, it demands comprehensive strategies including lifestyle changes, emerging pharmacological options, and novel diagnostic advancements. Understanding its challenges and evolving treatments is crucial for improving patient outcomes and addressing NASH liver disease. Understanding NASH: An […]

Nonalcoholic steatohepatitis (NASH) represents a serious health challenge linked to liver inflammation and fat accumulation. Closely tied to conditions like obesity and Type 2 diabetes, NASH can lead to liver damage and necessitates early diagnosis and effective management strategies. With no approved pharmacological treatments available, lifestyle modifications remain crucial, complemented by emerging research into nutraceuticals […]